Alkem was speculated to be the front runner to acquire JB Chem & Pharmaceuticals (JB) from KKR. Torrent had previously dropped out due to the valuation differences. However, finally it’s Torrent who acquires JB. Torrent will acquire 46.39% stake from promoters Tau Investment Holdings Pte Ltd (a unit of KKR) for Rs 11,917 crore; a … Read more
Private equity firm Advent International has signed a definitive agreement to invest $175 million (about ₹1,500 crore) for a significant minority stake in Felix Pharmaceuticals Pvt. Ltd, an Ireland-headquartered company focused on developing and manufacturing generic medicines for companion animals such as dogs, cats, and horses. This marks another bet by Advent in the growing … Read more
The initiative, part of the Promotion of Research & Innovation in Pharma MedTech Sector (PRIP) scheme—launched in August 2023 for a five-year period—seeks to boost domestic R&D and reduce India’s reliance on imported technology. Also read: DCGI seeks post-market surveillance data on 2 combination drugs within 3 months “We are planning to float the expression … Read more
Medicamen has recently won a new long term contract manufacturing contract from a US distributor. Company has now announced a board meeting on February 26, 2025 to consider a new fund raise. The intention is to raise some sort of equity (direct or convertible) by way of Preferential Issue/ Rights Issue/ QIP/ or any other … Read more
In a regulatory disclosure, Medicamen Biotech has informed that it has entered into a long-term Manufacturing & Supply Agreement with a prominent pharmaceutical distributor and marketing entity operating in the United States and Europe. Neither the name of the customer nor the financial details of the contract are disclosed. The company, however, has informed that collaboration … Read more
As on date, Opella Healthcare owns controlling stake of 60.37% in Sanofi Consumer Healthcare India (SCHIL). On October 21, 2024, Sanofi and Clayton, Dubilier & Rice, LLC (CD&R, the manager of the Clayton Dubilier & Rice private equity funds) have announced that they have entered into exclusive negotiations whereby CD&R Group has agreed to acquire … Read more
Chinese scientists claimed to have cured a chronic type-1 diabetes patient using cell transplants in what was stated to be the first such case in the world. The patient, a 25-year-old woman who had the chronic condition for over a decade, was able to naturally regulate her blood sugar some two and half months after … Read more